Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor

Journal of Clinical Microbiology

Volumn 43, Issue 4, 2005, Pages 2021-2023

  Christakis, George B ^a,c   Perlorentzou, Stavroula P ^a   Chalkiopoulou, Irene ^a   Athanasiou, Athanasios ^a   Legakis, Nikolas J ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GARENOXACIN; GATIFLOXACIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN;

ADULT; ARTICLE; BACTEREMIA; CASE REPORT; CATHETER; CHRYSEOBACTERIUM INDOLOGENES; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SOLID TUMOR; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CARCINOMA, SQUAMOUS CELL; CHRYSEOBACTERIUM; DRUG THERAPY, COMBINATION; FLAVOBACTERIACEAE INFECTIONS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NOSE NEOPLASMS; PENICILLANIC ACID; PIPERACILLIN;

EID: 16844381123     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.4.2021-2023.2005     Document Type: Article

References (18)

1. Aber, R. C., C. Wennersten, and R. C. Moellering, Jr. 1978. Antimicrobial susceptibility of flavobacteria. Antimicrob. Agents Chemother. 14:483-487.
2. Doiz, O., M. T. Llorente, A. Mateo, C. Seral, C. Garcia, and M. C. Rubio. 1999. Corneal abscess by Flavobacterium indologenes. Enferm. Infecc. Microbiol. Clin. 17:149-150.
3. Fraser, S. L., and J. H. Jorgensen. 1997. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob. Agents Chemother. 41:2738-2741.
4. Green, B. T., and N. E. Nolan. 2001. Cellulitis and bacteremia due to Chryseobacterium indologenes. J. Infect. 42:219-220.
5. Hsueh, P. R., L. J. Teng, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1996. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J. Clin. Microbiol. 34:1908-1913.
6. Hsueh, P. R., L. J. Teng, P. C. Yang, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1997. Increased incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 16:568-574.
7. Kienzle, N., M. Muller, and S. Pegg. 2001. Chryseobacterium in burn wounds. Burns 27:179-182.
8. Kirby, J. T., H. S. Sader, T. R. Walsh, and R. N. Jones. 2004. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Clin. Microbiol. 42:445-448.
9. Lin, J. T., W. S. Wang, C. C. Yen, J. H. Liu, T. J. Chiou, M. H. Yang, T. C. Chao, and P. M. Chen. 2003. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scan. J. Infect. Dis. 35:882-883.
10. Lu, P. C., and J. C. Chan. 1997. Flavobacterium indologenes keratitis. Ophthalmologica 211:98-100.
11. NCCLS. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Wayne, Pa.
12. Nulens, E., B. Bussels, A. Bols, B. Gordts, and H. W. Van Landuyt. 2001. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin. Microbiol. Infect. 7:391-393.
13. Pan, H. J., L. J. Teng, Y. C. Chen, P. R. Hsueh, P. C. Yang, S. W. Ho, and K. T. Luh. 2000, High protease activity of Chryseobacterium indologenes isolates associated with invasive infection. J. Microbiol. Immunol. Infect. 33:223-226.
14. Perola, O., T. Nousiainen, S. Suomalainen, S. Aukee, U.-M. Karkkainen, J. Kauppinen, T. Ojanen, and M.-L. Katila. 2002. Recurrent Sphingomonas paucimobilis-bacteremia associated with a multi-bacterial water-borne epidemic neutropenic patients. J. Hosp. Infect. 50:195-201.
15. Sanchez, M. F., P. R. Diaz, J. F. Ucelay, and D. A. Perez-Navaro. 1993. Pneumonia from Flavobacterium indologenes (group II B) in an immunodepressed patient. An. Med. Interna 10:312.
16. Schreckenberger, P. C., M. I. Daneshvar, R. S. Weyant, and D. G. Hollis. 2003. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods, p. 749-779. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
17. Vandamme, P., J. F. Bernardet, P. Segers, K. Kersters, and B. Holmes. 1994. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol. 44:827-831.
18. Yabuuchi, E., Y. Hashimoto, Y. Ezaki, Y. Ido, and N. Takeuchi. 1990. Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al. 1983 from Flavobacterium gleum Holmes et al. 1984. Microbiol. Immunol. 34:73-76.